This is an observational cohort study of long-living adults (participants aged 90 and above) from the Central Federal District of Russia. The study seeks to determine the genetic and cellular and molecular determinants of healthy longevity and to assess the impact of lifestyle and socioeconomic and environmental factors on healthy longevity. The study is expected to result in the development of a panel of markers of healthy longevity and/or a model of healthy aging based on the analysis of all factors under consideration.
The study involves a long-term observation of a cohort of long-living adults. During the first visit, a medical professional will take a detailed medical history and perform a comprehensive geriatric assessment (for 15 geriatric syndromes), and physical examination. The participants will have their biomaterials sampled for basic and extended blood biochemistry testing, telomere length measurement, common urine tests and subsequent biobanking and additional studies: whole genome sequencing, DNA methylation analysis, transcriptome analysis, and 16S RNA sequencing of stool and saliva. Follow-up checks will be carried out once a year by phone or during additional visits. The study seeks to identify the genetic, epigenetic, and metagenomic determinants associated with the successful and unsuccessful aging phenotypes, mortality, and survival in long-living individuals.
Study Type
OBSERVATIONAL
Enrollment
4,000
RUSSIAN CLINICAL AND RESEARCH CENTER OF GERONTOLOGY, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation
Moscow, Russia
RECRUITINGMortality among long-living adults
Mortality among long-living adults within at least 1 year after inclusion in the study and factors associated with mortality will be assessed.
Time frame: at least 1 year after inclusion in the study
Morbidity among long-living adults
Morbidity among long-living adults within at least 1 year after inclusion in the study and factors associated with morbidity will be assessed.
Time frame: at least 1 year after inclusion in the study
Aging phenotypes
Identification of successful and unsuccessful aging phenotypes
Time frame: at least 2 years after inclusion in the study
Social, economic, and medical- history-related determinants
Identification of social, economic, and medical- history-related determinants of successful and unsuccessful aging, geriatric syndromes
Time frame: at least 2 years after inclusion in the study
Genetic determinants
Identification of the genetic determinants of successful and unsuccessful aging, geriatric syndromes
Time frame: at least 2 years after inclusion in the study
Epigenetic determinants
Identification of the epigenetic determinants (methylation sites) of successful and unsuccessful aging, geriatric syndromes
Time frame: at least 2 years after inclusion in the study
Metagenomic determinants
Identification of the metagenomic determinants (16S-rSeq) of successful and unsuccessful aging, geriatric syndromes
Time frame: at least 2 years after inclusion in the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.